Sugi Predict

Sugi Predict / Compounds / SCHEMBL181579

SCHEMBL181579

SCHEMBL181579

CC1CC(=O)c2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 3/20 0.48
▸ TYMS P04818 1/20 0.46
▸ NOS3 P29474 1/20 0.44
▸ NOS1 P29475 1/20 0.44
▸ NOS2 P35228 1/20 0.44
▸ S100A4 P26447 1/20 0.44
▸ NOTUM Q6P988 2/20 0.43
▸ CSNK2A2 P19784 1/20 0.43
▸ CSNK2A1 P68400 1/20 0.43
▸ CYP19A1 P11511 3/20 0.41
▸ CYP11B2 P19099 2/20 0.41
▸ ADORA3 P0DMS8 2/20 0.41
▸ AR P10275 2/20 0.41
▸ HSD11B1 P28845 1/20 0.41
▸ AKR1C3 P42330 1/20 0.41
▸ TSHR P16473 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ HTR2C P28335 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9367273 1.00 ACHE (0.48) ACHETYMSNOS3NOS1NOS2
SCHEMBL20368206 1.00 ACHE (0.48) ACHETYMSNOS3NOS1NOS2
SCHEMBL31326549 1.00 ACHE (0.48) ACHETYMSNOS3NOS1NOS2
SCHEMBL9372008 1.00 ACHE (0.48) ACHETYMSNOS3NOS1NOS2
SCHEMBL3404418 0.92 ACHE (0.43) ACHETYMSNOS3NOS1NOS2
SCHEMBL3470602 0.88 KDM4E (0.51) ACHETYMSNOTUMCSNK2A2CSNK2A1
SCHEMBL8250749 0.79 ACHE (0.41) ACHETYMSNOTUMCSNK2A2CSNK2A1
SCHEMBL14169143 0.79 ACHE (0.41) ACHETYMSNOTUMCSNK2A2CSNK2A1
SCHEMBL13383479 0.79 ACHE (0.41) ACHETYMSNOTUMCSNK2A2CSNK2A1
SCHEMBL1339938 0.79 ACHE (0.41) ACHETYMSNOTUMCSNK2A2CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 487 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12628554-B2 Photoelectric conversion element, imaging element, optical sensor, and compound FUJIFILM CORPORATION (JP) 2026-05-12 — — US disclosed
US-12568754-B2 Laminate comprising a wavelength-conversion material and a wavelength-selective absorption layer, display device, and organic electroluminescent display device FUJIFILM CORPORATION (JP) 2026-03-03 — — US disclosed
US-20250393473-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, AND OPTICAL SENSOR FUJIFILM CORP (JP) 2025-12-25 — — US disclosed
US-12497359-B2 Acrylamide derivatives NRG THERAPEUTICS LTD (GB) 2025-12-16 — — US disclosed
US-20250374741-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFILM CORP (JP) 2025-12-04 — — US disclosed
US-12479989-B2 Wavelength selective absorption filter and organic electroluminescent display device FUJIFILM CORPORATION (JP) 2025-11-25 — — US disclosed
US-12484442-B2 Photoelectric conversion element, imaging element, optical sensor, and compound FUJIFILM CORPORATION (JP) 2025-11-25 — — US disclosed
US-20250351722-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFILM CORP (JP) 2025-11-13 — — US disclosed
US-20250346750-A1 WAVELENGTH SELECTIVE ABSORPTION FILTER AND ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2025-11-13 — — US disclosed
EP-4633333-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING DEVICE, PHOTOSENSOR, METHOD FOR PRODUCING IMAGING DEVICE, AND COMPOUND FUJIFILM Corporation (JP) 2025-10-15 — — EP disclosed
US-5185360-A Antioxidants, free radical scavengers UNIVERSITY OF BATH (GB) 1993-02-09 — — US disclosed
US-5093356-A Antiallergens, antiasthma, antiinflammatory, cytoprotective MERCK FROSST CANADA, INC. (CA) 1992-03-03 — — US disclosed
WO-1991000863-A1 HETEROARYL PIPERAZINE ANTIPSYCHOTIC AGENTS PFIZER INC. (US) 1991-01-24 — — WO disclosed
EP-0409435-A1 Heteroaryl piperazine antipsychotic agents PFIZER INC. (US) 1991-01-23 — — EP disclosed
WO-1990015800-A1 INDENOINDOLE COMPOUNDS UNIVERSITY OF BATH (GB) 1990-12-27 — — WO disclosed
EP-0404536-A1 Indenoindole compounds I UNIVERSITY OF BATH (GB) 1990-12-27 — — EP disclosed
US-4761403-A QUINOLONE DERIVATIVES ABBOTT LABORATORIES (US) 1988-08-02 — — US disclosed
EP-0240859-A2 Lipoxygenase inhibiting compounds ABBOTT LABORATORIES (US) 1987-10-14 — — EP disclosed
US-4076726-A Amidino-hydrazone derivatives AKZONA INCORPORATED (US) 1978-02-28 — — US disclosed
US-4028380-A Hydrazino-imidazole derivatives AKZONA INCORPORATED (US) 1977-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250351722-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND EPB41L2, PDE6C, CRY1 ACHE 2523/4885TYMS 3456/4885NOS3 2057/4885
US-12497359-B2 Acrylamide derivatives ACR, GSTA2, GSTA1 ACHE 963/4885TYMS 1448/4885NOS3 1481/4885
US-12568754-B2 Laminate comprising a wavelength-conversion material and a wavelength-selective absorption layer, display device, and organic electroluminescent display device STRA6, CDH1, EPCAM ACHE 2230/4885TYMS 4277/4885NOS3 434/4885
US-20250393473-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, AND OPTICAL SENSOR NR2E3, CRY1, CRY2 ACHE 4563/4885TYMS 4834/4885NOS3 4257/4885
US-12628554-B2 Photoelectric conversion element, imaging element, optical sensor, and compound SCO2, CRY2, PYM1 ACHE 4364/4885TYMS 4184/4885NOS3 3200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.